Pancreatic Cancer News and Research

RSS
Pancreatic cancer is the fourth leading cause of all cancer deaths in the United States and the third leading cause of cancer deaths in individuals ages 40 to 60. Approximately 37,000 Americans are diagnosed with pancreatic cancer each year, and, each year, approximately the same number die from it. Often, pancreatic cancer is found too late for surgical intervention, and chemotherapy and radiation treatments have little effect.
Study analyzes shifting pancreatic cancer burdens in US and China

Study analyzes shifting pancreatic cancer burdens in US and China

Experimental vaccines aim to treat and prevent aggressive cancers

Experimental vaccines aim to treat and prevent aggressive cancers

Experimental drug targets tumor barriers to unlock cancer-killing T cells

Experimental drug targets tumor barriers to unlock cancer-killing T cells

Blocking complement factor B halts pancreatic cancer growth

Blocking complement factor B halts pancreatic cancer growth

Pancreatic cancer shows distinct biological differences across racial groups

Pancreatic cancer shows distinct biological differences across racial groups

Stony Brook-developed cancer drug advances to human clinical trials

Stony Brook-developed cancer drug advances to human clinical trials

Mayo Clinic enters new medical era with precure research

Mayo Clinic enters new medical era with precure research

Targeting ANO6 protein weakens pancreatic cancer and boosts immunity

Targeting ANO6 protein weakens pancreatic cancer and boosts immunity

KRAS-targeting vaccine prompts immune responses in pancreatic cancer patients

KRAS-targeting vaccine prompts immune responses in pancreatic cancer patients

Targeted drug extends survival across diverse pancreatic cancer patient groups

Targeted drug extends survival across diverse pancreatic cancer patient groups

Researchers identify molecular target to improve pancreatic cancer treatment

Researchers identify molecular target to improve pancreatic cancer treatment

ECOG-ACRIN opens trial testing ivonescimab for aggressive bile duct cancer

ECOG-ACRIN opens trial testing ivonescimab for aggressive bile duct cancer

CT scans reveal body composition changes preceding pancreatic cancer diagnosis

CT scans reveal body composition changes preceding pancreatic cancer diagnosis

New AI model detects hidden diseases in routine CT scans

New AI model detects hidden diseases in routine CT scans

Researchers use mitochondrial uncouplers to target breast cancer metastasis

Researchers use mitochondrial uncouplers to target breast cancer metastasis

Pancreatic cancer cells continuously reshape DNA to evade treatment

Pancreatic cancer cells continuously reshape DNA to evade treatment

Single-cell analysis reveals how pancreatic cancer evades treatment

Single-cell analysis reveals how pancreatic cancer evades treatment

New research unveils role of innate immune system in pancreatic cancer

New research unveils role of innate immune system in pancreatic cancer

Combination therapy overcomes immunotherapy resistance in glioblastoma

Combination therapy overcomes immunotherapy resistance in glioblastoma

Nerve-stimulation device enters human trials for cancer-related cachexia

Nerve-stimulation device enters human trials for cancer-related cachexia

While we only use edited and approved content for Azthena answers, it may on occasions provide incorrect responses. Please confirm any data provided with the related suppliers or authors. We do not provide medical advice, if you search for medical information you must always consult a medical professional before acting on any information provided.

Your questions, but not your email details will be shared with OpenAI and retained for 30 days in accordance with their privacy principles.

Please do not ask questions that use sensitive or confidential information.

Read the full Terms & Conditions.